Triamcinolone acetonide: A review of its pharmacological properties and therapeutic efficacy in the management of allergic rhinitis

Drugs

Volumn 53, Issue 2, 1997, Pages 257-280

  Jeal, Wendy ^a   Faulds, Diana ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ASTEMIZOLE; BECLOMETASONE; FLUNISOLIDE; FLUTICASONE PROPIONATE; LORATADINE; TRIAMCINOLONE ACETONIDE;

AEROSOL; ALLERGIC RHINITIS; CLINICAL TRIAL; DRUG ABSORPTION; DRUG EFFICACY; DRUG FORMULATION; EOSINOPHILIA; EPISTAXIS; EYE DISEASE; HEADACHE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INHALATIONAL DRUG ADMINISTRATION; METERED DOSE INHALER; NOSE DISEASE; ORAL DRUG ADMINISTRATION; REVIEW; SNEEZING; SORE THROAT; SYMPTOM; SYSTEMIC CIRCULATION;

EID: 0031014884     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199753020-00006     Document Type: Review

References (73)

1. Pavord I, Knox A. Pharmacokinetic optimisation of inhaled steroid therapy in asthma. Clin Pharmacokinet 1993 Aug; 25: 126-35
2. Argenti D, Colligon I, Heald D, et al. Nasal mucosal inflammation has no effect on the absorption of intranasal triamcinolone acetonide. J Clin Pharmacol 1994 Aug; 34: 854-8
3. Golub JR. Long-term triamcinolone acetonide aerosol treatment in adult patients with chronic bronchial asthma. Ann Allergy 1980 Mar; 44: 131-7
4. Falliers CJ, Petraco AJ. Control of asthma with triamcinolone acetonide aerosol inhalations at 12-hour intervals. J Asthma 1982; 19: 241-7
5. Nasacort nasal inhaler (triamcinolone acetonide) product monograph (Rhone-Poulene Rorer Phermaceuticals Inc.; Pennsylvania).
6. Summary of product characterisics Nasacort AQ. Rhone-Poulene Rorer, 1996. (Data on file).
7. Mygind N. Glucocorticosteroids and rhinitis. Allergy 1993 Oct; 48: 476-90
8. Naclerio RM, Proud D, Togias AG, et al. Inflammatory mediators in late antigen induced rhinitis. N Engl J Med 1985 Jul 11: 313 (2): 65-70
9. Tinkelman D, Falliers C, Gross G, et al. Multicenter evaluation of triamcinolone acetonide nasal aerosol in the treatment of adult patients with seasonal allergic rhinitis. Ann Allergy 1990 Feb; 64: 234-40
10. Spector S, Bronsky E, Chervinsky P, et al. Multicenter, double-blind, placebo-controlled trial of triamcinolone acetonide nasal aerosol in the treatment of perennial allergic rhinitis. Ann Allergy 1990 Mar; 64: 300-5
11. Findlay S, Huber F, Garcia J. Efficacy of once-a-day intranasal administration of triamcinolone acetonide in patients with seasonal allergic rhinitis. Ann Allergy 1992 Mar; 68: 228-32
12. Storms W, Bronsky E, Findlay S, et al. Once daily triamcinolone acetonide nasal spray is effective for the treatment of perennial allergic rhinitis. Ann Allergy 1991 Apr; 66: 329-34
13. Storms W, Bernstein D, LaForce C, et al. Prophylactic use of topical triamcinolone acetonide nasal inhaler in patients with seasonal allergic rhinitis [abstract no. 999]. J Allergy Clin Immunol 1996 Jan; 97 (1 Pt 3): 432
14. Creticos PS, Bernstein DI, Proud D, et al. Triamcinolone acetonide nasal aerosol versus astemizole in patients with seasonal ragweed allergic rhinitis [abstract]. J Allergy Clin Immunol 1994 Jan; 93 (Pt 2): 177
15. Wood RA, Eggleston PA. The effects of intranasal steroids on nasal and pulmonary responses to cat exposure. Am J Respir Crit Care Med 1995 Feb; 151 (Pt 1): 315-20
16. Munk Z, Gross G, Hampel Jr F, et al. Prophylactic use of triamcinolone acetonide nasal inhaler in patients with seasonal ragweed induced allergic rhinitis. [abstract no. 224]. J Allergy Clin Immunol 1995 Jan; 95 (2): 198
17. Data on file. Rhône-Poulene Rorer, 1996
18. Amos WMG. Antibody function. In: Basic immunology, first ed. Bodmin: Butterworths & Co. Ltd. 1981: 44-8
19. Nuclerio RM, Adkinson Jr NF, Creticos PS, et al. Intranasal steroids inhibit seasonal increases in ragweed-specific immunoglobulin E antibodies. J Allergy Clin Immunol 1993 Nov; 92: 717-21
20. Kobayashi RH, Beaucher WN, Koepke JW, et al. Triamcinolone acetonide aqueous nasal spray for the treatment of patients with perennial allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled study. Clin Ther 1995 May-Jun; 17: 503-13
21. Settipane G, Korenblat PE, Winder J, et al. Triamcinolone acetonide aqueous nasal spray in patients with seasonal ragweed allergic rhinitis: a placebo-controlled, double-blind study. Clin Ther 1995 Mar-Apr; 17: 252-63
22. Day JH, Buckeridge DL, Clark RH, et al. A randomised, double-blind, placebo-controlled, controlled antigen delivery study of the onset of action of aerosolized triamcinolone acetonide nasal spray in subjects with ragweed-induced allergic rhinitis. J Allergy Clin Immunol 1996; 97: 1050-7
23. Spector SL, English G, Jones L. Clinical and nasal biopsy response to treatment of perennial rhinitis. J Allergy Clin Immunol 1980; 66 No. 2: 129-37
24. Jones LM, Spector SL, English GM, et al. Treatment of perennial rhinitis with flunisolide corticosteroid spray. Ann Allergy 1979 Mar; 42: 139-44
25. Law CM, Marchant JL, Honour JW, et al. Nocturnal adrenal supression in asthmatic children taking inhaled beclomethasone diproprionate. Lancet 1986 Apr 26; 1: 942-4
26. Pedersen S, Fuglsang G. Urine cortisol excretion in children treated with high doses of inhaled corticosteroids: a comparison of budesonide and beclomethasone. Eur Respir J 1988; 1: 433-5
27. Springer C, Avital A, Maayan CH, et al. Comparison of budesonide and beclomethasone dipropionate fir treatment of asthma. Arch Dis Child 1987; 62: 815-9
28. Sherman B, Weinberger M, Chen-Waiden H, et al. Further studies of the effects of inhaled glucocorticoids on pituitary-adrenal function in healthy adults. J Allergy Clin Immunol 1982; 69 (2): 208-12
29. Feiss G, Morris R, Rom D, et al. A comparative study of the effects of intranasal triamcinolone acetonide aerosol (ITAA) and prednisone on adrenocortical function. J Allergy Clin Immunol 1992 Jun; 89: 1151-6
30. Schenkel EJ, Ellis MH, Gross G, et al. Triamcinolone acetonide aqueous nasal spray does not alter adrenocortical function in children with allergic rhinitiz. [abstract 61]. J Allergy Clin Immunol 1996 Jan; 97 (1 Pt 3): 198
31. Howland III WC, Dockhorn R, Gillman S, et al. A comparison of effects of triamcinolone acetonide aqueous nasal spray, oral prednisone, and placebo on adrenocorlical function in male patients with allergic rhinitis. J Allergy Clin Immunol 1996; 98 (1): 32-8
32. Paull B, Ziemniak J, Smith JA, et al. A pharmacokinetic comparison of triamcinolone acetonide (Kenalog R-40 vs Nasacort TM) in patients with allergic rhinitis [abstract]. Ann Allergy 1991 Jan; 66: 92
33. Derendorf H, Mollmann H, Gruner A, et al. Pharmacokinetics and pharmacodynamics of glucocorticoid suspensions after intra-articular administration. Clin Pharmacol Ther 1986; 39: 313-7
34. Hensel R, Mullen ME. Pharmacokinetic report: An open label pharmacokinetic study of RG5029Y (triamcinolone acetonide) aqueous nasal spray and Nasacort nasal inhaler. Rhône-Poulenc Rorer, 1993. Protocol number RG 5029Y-101 (Data on file)
35. Heald DL, Bednarczyk EM, Bordeaux K, et al. Regional distribution of 11C-labeled triamcinolone acetonide following intranasal administration in healthy volunteers [abstract] (95th Annual Meeting American Society for Clinical Pharmacology and Therapeutics; 183).
36. Heald D, Berridge M, Muswick G, et al. Nasal biodistribution and pharmacokinetics of an aqueous formulation of triamcinolone acetonide utilizing positron emission tomography (PET). Rhône-Poulenc Rorer, 1996. (Data on file).
37. Mackay IS. Classification and differential diagnosis of rhinitis. Eur Resp Rev 1994; 4 (20): 245-7
38. Munk ZM, LaForce C, Furst JA, et al. Efficacy and safety of triamcinolone acetonide aqueous nasal spray in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 1996 Oct; 77: 277-81
39. Smith JA, Schenkel EJ, Gross G, et al. Efficacy and safety of once-daily triamcinolone acetonide aqueous nasal spray in pediatric patients with spring grass seasonal allergic rhinitis [abstract no. 60]. J Allergy Clin Immunol 1996 Jan; 97 (1 Pt 3): 57
40. Goldberg P, Simpson B. Safety and eficacy of triamcinolone acetonide aqueous nasal spray in children with perennial allergic rhinitis (abstract). Rhône-Poulenc Rorer, 1996. Study number 314 (Data on file).
41. Banov CH, Silvers WS, Green AW, et al. Placebo-controlled, double-Mind study of the efficacy and safely of triamcinolone acetonide aerosol nasal inhaler in pediatric patients with seasonal allergic rhinitis. Clin Ther 1996 Mar-Apr; 18 (2): 265-72
42. Storms WW, Southern L, Feiss G, et al. Efficacy of triamcinolone acetonide aerosol nasal inhaler in children with perennial allergic rhinitis. Pediatr Asthma Allergy Immunol 1996; 10 (2): 59-64
43. Welch MJ, Bronsky EA, Grossman J, et al. Clinical evaluation of triamcinolone acetonide nasal aerosol in children with perennial allergic rhinitis. Ann Allergy 1991 Nov; 67: 493-8
44. Storms B, Procaccini RL, Smith JA. Evaluation of the topical versus systemic effects of triamcinolone acetonide aqueous nasal spray in allergic rhinitis [abstract]. J Allergy Clin Immunol 1995 Jan; 95 (Pt 2): 196
45. Gross G, Boggs P, Ginchansky E, et al. The efficacy of triamcinolone acetonide aqueous nasal spray for seasonal allergic rhinitis is due to topical effects [abstract]. Ann Allergy Asthma Immunol 1996 Jan; 76: 95
46. Gross G, Boggs P, Ginchansky E, et al. A placebo-controlled, double-blind comparison of topical versus systemic triamcinolone acetonide aqueous nasal spray in seasonal allergic rhinitis. Rhône-Poulenc Rorer, 1995. Study number 308. (Data on file)
47. Scadding GK, Lund VJ, Holmstrom M, et al. Clinical and physionogical effect of fluticasone propionate aqueous nasal spray in the treatment of perennial rhinitis. Rhinology 1991 Suppl. 11: 37-43
48. Lebowitz RA, Jacobs JB. Rhinomanometric and clinical evaluation of triamcinolone acetonide and beclomethasone dipropionate in rhinitis. Am J Rhinol 1993 May-Jun; 7: 121-4
49. Grossman J, Ball R, Shulan D, et al. A comparison of the systemic availability of triamcinolone acetonide aerosol (Nasacort (Rm)) in men with and without active rhinitis [abstract]. J Allergy Clin Immunol 1991 Jan; 87: 154
50. Welch MJ, Bronsky E, Findlay S, et al. Long-term safety of triamcinolone acetonide nasal aerosol for the treatment of perennial allergic rhinitis. Clin Ther 1994 Mar-Apr; 16; 253-62
51. Smith JA, Kobayashi RH, Beaucher WN, et al. Triamcinoline acetonide aqueous nasal spray for the long-term treatment of perennial allergic rhinitis [abstract]. Ann Allergy Asthma Immunol 1996 Jan; 76: 96
52. Winder J, Bell T, Brodsky L, et al. A comparative study of intranasal triamcinalone acetonide aerosol and intranasal beclomethasone dipropionate aqueous spray in perennial allergic rhinitis. Immunology and Allergy Practice 1993 Jul; 15 (7): 8-14
53. Nsouli SM, Nsouli TM, Bellanti JA. Treatment of allergic rhinitis beclomethasone dipropionate (BD) versus triamcinolone acetonide (TA) [abstract]. Ann Allergy 1994 Jan; 72: 83
54. Grubbe R, Adelglass J, Casale T, et al. Triamcinolone acetonide nasal inhaler vs beclomethasone diproprionate nasal spray in patients with perennial allergic rhinitis [abstract]. 1994 (1994 Annual Meeting - American College of Allergy and Immunology: 3)
55. LaForce C, Hampel F, Kiechel F, et al. Comparison of once-daily triamcinolone acetonide aqueous nasal spray and twice-daily Beconase AQ for the treatment of seasonal allergic rhinitis due to ragweed. [abstract no. 1002]. J Allergy Clin Immunol 1996 Jan; 97 (1 Pt 3): 433
56. Small P, Houle PA, Day J, et al. Triamcinolone acetonide nasal spray (T) vs fluticasone propionate aqueous nasal spray (F) in patients with seasonal allergic rhinitis. [abstract no. 1003]. J Allergy Clin Immunol 1996 Jan: 97 (1 Pt 3): 433
57. Van Bavel J, Blumenfeld R, Huang S, et al. Intranasal triamcinolone acetonide aerosol vs flunisolide spray (FS) in perennial allergic rhinitis (PAR). [abstract no. P55]. Ann Allergy 1992 Jan; 68: 107
58. Bernstein DI, Creticos PS, Busse WW, et al. Comparison of triamcinolone acetonide nasal inhaler with astemizole in the treatment of ragweed-induced allergic rhinitis. J Allergy Clin Immunol 1996; 97: 749-55
59. Schoenwetter W, Lim J. Comparison of intranasal triamcinolone acetonide with oral loratidine for the treatment of patients with seasonal allergic rhinitis. Clin Ther 1995 May-Jun; 17: 479-92
60. Gold M, Small P, Patel P, et al. Triamcinolone acetonide nasal spray (T) vs loratadine tablets (L) vs T + L in patients with spring pollen allergic rhinoconjunctivitis (RC). [abstract no. 1000]. J Allergy Clin Immunol 1996 Jan; 97 (1 Pt 3): 432
61. Brown DC, Savacool AM, Letizia CM. A retrospective review of the effects of one year of triamcinolone acetonide aerosol treatment on the growth patterns of asthmatic children. Ann Allergy 1989 Jul; 63: 47-51
62. Welch MJ. Inhaled steroids and severe viral infections. J Asthma 1994; 31 (1): 43-50
63. Naclerio RM. Allergic rhinitis. N Engl J Med 1991 Sep 19; 325 (12): 860-9
64. Noble S, McTavish D. Levocabastine: an update of its pharmacology, clinical efficacy and tolerability in the topical treatmant of allergic rhinitis and conjunctivitis. Drugs 1995 Dec; 50 (6): 1032-44
65. Mabry RL. Topical pharmacotherapy for allergic rhinitis: new agents. South Med J 1992 Feb; 85: 149-54
66. Welch MJ. Topical nasal steroids for allergic rhinitis. West J Med 1993 Jun; 158: 616-7
67. Mabry RL. Corticosteroids in the management of upper respiratory allergy: the emerging role of steroid nasal sprays. Otolaryngol Head Neck Surg 1992 Dec; 107: 855-60
68. Mygind N, Lund V. Topical corticosteroid therapy of rhinitis: a review. Clin Immunother 1996 Feb; 5: 122-36
69. Krause HF. Pharmacotherapy or perennial and seasonal allergic rhinitis. Clin Immunother 1995; 3 (4): 308-24
70. Dolovich J, Wong AG, Chodirker WB, et al. Multicenter trial of fluticasone propionate aqueous nasal spray in ragweed allergic rhinitis. Ann Allergy 1994 Aug; 73: 147-53
71. Lund VJ. Practical application of the International Consensus on the management of rhinitis. Clin Immunother 1995; 4 (4): 270-8
72. Banov CH, Woehler TR, LaForce CF, et al. Once daily intranasal fluticasone propionate is effective for perennial allergic rhinitis. Ann Allergy 1994 Sep; 73: 240-6
73. Knutsson U, Stierna P, Marcus C, et al. Effects of intranasal glucocorticoids on endogenous glucocorticoid peripheral and central function. J Endocrinol 1995; 144: 301-10